AI in Life Sciences Industry Overview
Artificial intelligence in the Life Sciences Market is highly competitive and consists of several major players. The market is moderately concentrated. The major players with prominent shares in the market are focusing on expanding their customer base across foreign countries. These companies are leveraging strategic collaborative initiatives to increase their market share and increase their profitability. The companies operating in the market are also acquiring start-ups working on artificial intelligence in life sciences technologies to strengthen their product capabilities.
In November 2022, XtalPi Inc. announced that the company is looking forward to a strategic partnership with CK Life Sciences. In order to enhance the discovery and design skills of tumor vaccines and speed up the creation of new vaccine kinds, this collaboration will take advantage of their individual expertise to establish a revolutionary AI tumor vaccine R&D platform. In June 2022, Amgen's R&D announced the partnership with The Scientist; this collaboration examines cutting-edge drug discovery and development methods that use artificial intelligence (AI) and machine learning to create brand-new protein therapies.
AI in Life Sciences Market Leaders
-
IBM Corporation
-
NuMedii Inc.
-
Atomwise Inc
-
AiCure LLC
-
Nuance Communications Inc.
- *Disclaimer: Major Players sorted in no particular order
